Skip to main content
. 2020 Sep 30;133(22):2674–2681. doi: 10.1097/CM9.0000000000001135

Table 1.

Demographic and clinical characteristics of DES-ISR patients after PCI.

Variables Early ISR (n = 32) Late ISR (n = 218) P
Age (years) 58.5 (48.8–63.8) 61 (54.0–67.0) 0.103
Male 22 (22.0) 176 (80.7) 0.119
BMI (kg/m2) 26.2 (24.0–28.1) 25.8 (24.1–27.7) 0.844
Diabetes mellitus 12 (37.5) 83 (38.1) 0.950
Hypertension 21 (65.6) 150 (68.8) 0.718
Dyslipidemia 26 (81.3) 196 (89.9) 0.144
Apoplexy 5 (15.6) 29 (13.3) 0.782
Atrial fibrillation 2 (6.3) 9 (4.1) 0.637
CKD 1 (3.1) 4 (1.8) 0.499
Prior MI 12 (37.5) 65 (29.8) 0.379
Prior CABG 1 (3.1) 7 (3.2) 1.000
Prior surgery 4 (12.5) 42 (19.3) 0.356
Peripheral vascular history 1 (3.1) 15 (6.9) 0.702
History of smoking 17 (53.1) 134 (61.5) 0.368
Smoking within 1 month 7 (21.9) 51 (23.4) 0.849
History of drinking 11 (34.4) 113 (51.8) 0.065
Family history of CHD 7 (21.9) 44 (20.2) 0.825
History of interruption APT 0 (0) 24 (11.0) 0.052
Symptoms on admission 0.088
 Stable angina 12 (37.5) 39 (17.9)
 Unstable angina 19 (59.4) 165 (75.7)
 NSTEMI 1 (3.1) 8 (3.7)
 STEMI 0 (0) 6 (2.8)
Killip class >II or NYHA class >II 10 (31.3) 100 (45.9) 0.120
Prior PCI counts 1 (1–2) 1 (1–2) 0.929
Stent amounts 3 (2–4) 2 (1–4) 0.110
Stented vessel counts 1 (1–2) 2 (1–2) 0.639
In-hospital time (days) 5 (3–6) 4 (3–5) 0.221
Period of ISR (years) 0.8 (0.5–0.9) 5.1 (2.4–7.5) <0.001

Data are presented as median (range) or n (%). APT: Antiplatelet therapy; BMI: Body mass index; CABG: Coronary artery bypass grafting; CKD: Chronic kidney disease; DES: Drug-eluting stent; ISR: In-stent restenosis; MI: Myocardial infarction; NSTEMI: Non-ST-segment elevated myocardial infarction; NYHA: New York Heart Association; PCI: Percutaneous coronary intervention; STEMI: ST-segment elevated myocardial infarction.